Nirma Khatri Vadlamudi
Assistant Professor | University of Florida
Gainesville, FL, UNITED STATES
Dr. Nirma Khatri Vadlamudi is an expert in the area of epidemiology and health economics for vaccine-preventable diseases.
Biography
Dr. Nirma Khatri Vadlamudi is an assistant professor in the Department of Pharmaceutical Outcomes and Policy in the College of Pharmacy. Dr. Vadlamudi’s research program focuses on generating evidence on comparative effectiveness, safety, epidemiological burden, and economic evaluation to inform the design and implementation of innovative infectious disease prevention strategies to improve population health.
Areas of Expertise (4)
Rotavirus Vaccines
Pneumococcal Vaccines
Vaccination
RSV Vaccines
Media Appearances (2)
How measles spreads and why its spreading now
CBC Listen radio
2024-03-05
Vancouver Coastal Health reported B.C.’s first case of the highly-contagious measles virus since 2019. An infectious disease epidemiologist shares insights into immunization rates.
Nearly half of Canadian kids admitted to hospital with RSV under 6 months old: study
Vancouver Sun online
2023-10-04
A new study suggests nearly half of Canadian kids hospitalized with respiratory syncytial virus are under six months old, raising concerns that more preventive measures are needed. RSV, which can cause respiratory tract infections such as bronchiolitis and pneumonia, is one of the leading causes of hospitalizations among children, according to health experts.
Articles (3)
Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic
JAMA NetworkMalou Bourdeau, et. al
2023-10-02
Respiratory syncytial virus (RSV) is a leading cause of pediatric hospitalizations. To describe the epidemiology and burden of RSV-associated hospitalizations among children and adolescents in Canadian tertiary pediatric hospitals from 2017 to 2022, including changes during the COVID-19 pandemic.
The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review
PLOS Global Public HealthNirma Khatri Vadlamudi, et. al
2023-07-19
Whether SARS-CoV-2 infection and its management influence tuberculosis (TB) treatment outcomes is uncertain. We synthesized evidence on the association of SARS-CoV-2 coinfection (Coinfection Review) and its management (Clinical Management Review) on treatment outcomes among people with tuberculosis (TB) disease.
Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study
Value HealthNirma Khatri Vadlamudi, et. al
2022-09-25
Invasive pneumococcal disease (IPD) and a variety of clinical syndromes caused by pneumococci, such as acute otitis media (AOM), acute sinusitis (AS), and community-acquired pneumonia (CAP), cause a substantial burden on healthcare systems.
